Clinical Trial Detail

NCT ID NCT01535053
Title Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements no
Sponsors Gynecologic Oncology Group
Indications

choriocarcinoma

gestational trophoblastic neoplasm

Therapies

Leucovorin

Dactinomycin

Methotrexate

Age Groups: adult

No variant requirements are available.